Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

Stopping GLP-1 therapy may disrupt glycemic control and reduce cardiovascular benefits without clear perioperative safety ...

“This drug isn't going to wipe out a whole statistic of women,” the supermodel and activist said of the popular weight-loss ...

Ashley Graham calls the rise of GLP-1 weight loss shots disheartening as she vows to continue advocating for plus-size women ...

Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for childhood obesity.

Available evidence suggests GLP-1 receptor agonists warrant consideration as an adjunct to conventional treatments for ...

Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness ...

Ashley Graham criticises GLP-1 drugs and Ozempic trend, calling it a 'smack in the face' to body positivity in Hollywood and fashion.

The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...

Ashley Graham is not happy with what the prevalence of GLP-1 drugs is doing to body positivity. The popular plus-size model is the cover star of Marie Claire’s latest Motherhood Issue, and she ...

The Trump administration has postponed its five-year BALANCE pilot for Medicare GLP-1 weight-loss drug coverage after insurers balked, but will continue a temporary 'Medicare GLP-1 Bridge' program ...